ERG and prostate carcinoma: Additional studies using prostate cancer models showed phosphorylation of ERG at residues in the N-terminal degron by casein kinase I δ, which triggers ubiquitination by the Cullin3-SPOP E3 ubiquitin ligase complex and consequent degradation [47,48].